195 related articles for article (PubMed ID: 37856423)
21. Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast.
Vidal M; Peg V; Galván P; Tres A; Cortés J; Ramón y Cajal S; Rubio IT; Prat A
Mol Oncol; 2015 Jun; 9(6):1081-90. PubMed ID: 25687451
[TBL] [Abstract][Full Text] [Related]
22. Repeat recurrence and malignant transition of phyllodes tumors of the breast.
Wada A; Hayashi N; Endo F; Tsunoda H; Yoshida A; Suzuki K; Nakamura S; Yamauchi H
Breast Cancer; 2018 Nov; 25(6):736-741. PubMed ID: 29951882
[TBL] [Abstract][Full Text] [Related]
23. Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation.
Nie Y; Chen J; Huang D; Yao Y; Chen J; Ding L; Zeng J; Su S; Chao X; Su F; Yao H; Hu H; Song E
Cancer Res; 2017 Jul; 77(13):3605-3618. PubMed ID: 28512246
[TBL] [Abstract][Full Text] [Related]
24. Phyllodes tumor of the breast: role of Axl and ST6GalNAcII in the development of mammary phyllodes tumors.
Ren D; Li Y; Gong Y; Xu J; Miao X; Li X; Liu C; Jia L; Zhao Y
Tumour Biol; 2014 Oct; 35(10):9603-12. PubMed ID: 24961352
[TBL] [Abstract][Full Text] [Related]
25. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157
[TBL] [Abstract][Full Text] [Related]
26. Synergistic killing effect between vorinostat and target of CD146 in malignant cells.
Ma X; Liu J; Wu J; Yan X; Wu P; Liu Y; Li S; Tian Y; Cao Y; Chen G; Meng L; Xu G; Wang S; Lu Y; Ma D; Zhou J
Clin Cancer Res; 2010 Nov; 16(21):5165-76. PubMed ID: 20884621
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast.
Takizawa K; Yamamoto H; Taguchi K; Ohno S; Tokunaga E; Yamashita N; Kubo M; Nakamura M; Oda Y
Hum Pathol; 2016 Sep; 55():30-8. PubMed ID: 27137988
[TBL] [Abstract][Full Text] [Related]
28. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.
Kim GE; Kim JH; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):298-303. PubMed ID: 22505012
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.
Jones AM; Mitter R; Springall R; Graham T; Winter E; Gillett C; Hanby AM; Tomlinson IP; Sawyer EJ;
J Pathol; 2008 Apr; 214(5):533-44. PubMed ID: 18288784
[TBL] [Abstract][Full Text] [Related]
30. Versican core protein aids in the diagnosis and grading of breast phyllodes tumor.
Zhang L; Bi J; Yu X; Li X; Liu X; Weng X; Shao M
Ann Diagn Pathol; 2023 Oct; 66():152176. PubMed ID: 37423116
[TBL] [Abstract][Full Text] [Related]
31. MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours.
Garcia-Dios DA; Levi D; Shah V; Gillett C; Simpson MA; Hanby A; Tomlinson I; Sawyer EJ
Br J Cancer; 2018 Jan; 118(2):277-284. PubMed ID: 29315289
[TBL] [Abstract][Full Text] [Related]
32. Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions.
Chen PH; Bossuyt V; Reisenbichler E
Hum Pathol; 2021 Feb; 108():68-75. PubMed ID: 33245988
[TBL] [Abstract][Full Text] [Related]
33. Increased p53 protein expression in malignant mammary phyllodes tumors.
Tse GM; Putti TC; Kung FY; Scolyer RA; Law BK; Lau TS; Lee CS
Mod Pathol; 2002 Jul; 15(7):734-40. PubMed ID: 12118111
[TBL] [Abstract][Full Text] [Related]
34. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
[TBL] [Abstract][Full Text] [Related]
35. How Wide Should Margins Be for Phyllodes Tumors of the Breast?
Tremblay-LeMay R; Hogue JC; Provencher L; Poirier B; Poirier É; Laberge S; Diorio C; Desbiens C
Breast J; 2017 May; 23(3):315-322. PubMed ID: 27901301
[TBL] [Abstract][Full Text] [Related]
36. Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade.
Yoon N; Bae GE; Kang SY; Choi MS; Hwang HW; Kim SW; Lee JE; Nam SJ; Gong G; Lee HJ; Bae YK; Lee A; Cho EY
Genes Chromosomes Cancer; 2016 Jun; 55(6):495-504. PubMed ID: 26856273
[TBL] [Abstract][Full Text] [Related]
37. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
[TBL] [Abstract][Full Text] [Related]
38. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.
Zhang Y; Kleer CG
Arch Pathol Lab Med; 2016 Jul; 140(7):665-71. PubMed ID: 27362571
[TBL] [Abstract][Full Text] [Related]
39. A retrospective review of phyllodes tumors of the breast from a single institution.
Yuniandini A; Hamdani W; Prihantono P; Faruk M
Breast Dis; 2021; 40(S1):S63-S70. PubMed ID: 34092583
[TBL] [Abstract][Full Text] [Related]
40. Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor.
Kim HM; Lee YK; Koo JS
Dis Markers; 2016; 2016():4218989. PubMed ID: 27881889
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
